Open AccessReview of nintedanib plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso trial
Author(s) -
Pyng Lee
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.07.105
Subject(s) - medicine , pemetrexed , nintedanib , mesothelioma , cisplatin , placebo , oncology , chemotherapy , pathology , lung , idiopathic pulmonary fibrosis , alternative medicine